Resolutions of the 31st Annual General Meeting of DocMorris AG of 2 May 2024 in Zurich
All members of the Board of Directors and the Nomination and Compensation Committee were confirmed for a further term of office until the next Annual General Meeting.
- All members of the Board of Directors and the Nomination and Compensation Committee were confirmed for a further term of office until the next Annual General Meeting.
- Buis Bürgi AG as independent proxy and Ernst & Young AG as auditors were re-elected.
- The company was renamed from Zur Rose Group AG to DocMorris AG in May 2023 after the Swiss business was sold to Migros/Medbase.
- The shares of DocMorris AG are listed on the SIX Swiss Exchange (securities number 4261528, ISIN CH0042615283, ticker DOCM).